Skip to main content
Clinical Trials/ISRCTN45415158
ISRCTN45415158Completed未知

Breath test for patients with acute liver disease for early detection of the need for transplant or recovery: a multicentre non-randomised study

Exalenz Bioscience Ltd (Israel)0 sites30 target enrollmentStarted: February 11, 2010Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
30

Study Overview

Study Design

Study Type
Interventional

Eligibility Criteria

Sex
All

Inclusion Criteria

  • 1. Adult men or women (greater than 18 years of age)
  • 2. Acute liver insult
  • 3. No evidence of cirrhosis (unless clinical acute Wilsons)
  • 4. International Normalised Ratio (INR) greater than 1.8
  • 5. Duration of illness less than 12 or 24 weeks (to be determined [TBD])

Exclusion Criteria

  • 1. Any chronic liver disease
  • 2. Severe congestive heart failure
  • 3. Severe pulmonary hypertension
  • 4. Chronic renal insufficiency with severe cardiac disease
  • 5. Previous surgical bypass surgery for morbid obesity
  • 6. Extensive small bowel resection
  • 7. Any autoimmune disorder, which is currently being treated with prednisone or any other immune suppressive medication
  • 8. Recipient of any organ transplant
  • 9. Proven or suspected hepatocellular carcinoma
  • 10. Pregnant
  • 11. Allergic to paracetamol (such as Tylenol® or any other related medications)
  • 12. History of chronic obstructive pulmonary disease or symptomatic bronchial asthma
  • 13. Septic cholestasis
  • 14. Currently receiving total parenteral nutrition if they have contraindications to oral drugs
  • 15. Taking hepatotoxin drugs
  • 16. Hypersensitivity to paracetamol
  • 17. Based on the opinion of the investigator, patient should not be enrolled into this study
  • 18. Unable or unwilling to sign informed consent
  • 19. Participating in other clinical trials evaluating experimental treatments or procedures

Investigators

Sponsor
Exalenz Bioscience Ltd (Israel)

Similar Trials